Chiun-Sheng Huang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 20

Top Topics

Early Breast Cancer

Epidermal Growth Factor Receptor

Induced Pluripotent Stem Cells

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JMIR formative research

NPJ breast cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Gnant, Khatijah Lim Abdullah, Frances M Boyle, Chiun-Sheng Huang, Katie Bickford, Sola Quasheba Neunie, Alexander Daniel Noble, Anne Nunn, Caroline Sproat, Nadia Harbeck, Carlos Henrique Barrios
Assessing Knowledge, Competence, and Performance Following Web-Based Education on Early Breast Cancer Management: Health Care Professional Questionnaire Study and Anonymized Patient Records Analysis. JMIR formative research 8 (2024)
Michael Gnant, Khatijah Lim Abdullah, Frances M Boyle, Chiun-Sheng Huang, Katie Bickford, Sola Quasheba Neunie, Alexander Daniel Noble, Anne Nunn, Caroline Sproat, Nadia Harbeck, Carlos Henrique Barrios
Assessing Knowledge, Competence, and Performance Following Web-Based Education on Early Breast Cancer Management: Health Care Professional Questionnaire Study and Anonymized Patient Records Analysis. JMIR formative research 8 (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Michael Gnant, Khatijah Lim Abdullah, Frances M Boyle, Chiun-Sheng Huang, Katie Bickford, Sola Quasheba Neunie, Alexander Daniel Noble, Anne Nunn, Caroline Sproat, Nadia Harbeck, Carlos Henrique Barrios
Assessing Knowledge, Competence, and Performance Following Web-Based Education on Early Breast Cancer Management: Health Care Professional Questionnaire Study and Anonymized Patient Records Analysis. JMIR formative research 8 (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Sibylle Loibl, Jacek Jassem, Amir Sonnenblick, Damien Parlier, Eric P Winer, Jonas Bergh, Richard D Gelber, Eleonora Restuccia, Young-Hyuck Im, Chiun-Sheng Huang, Florence Dalenc, Isabel Calvo, Marion Procter, Carmela Caballero, Emma Clark, Alice Raimbault, Robin McConnell, Estefania Monturus, Evandro de Azambuja, Henry Leonidas Gómez, Judith M Bliss, Giuseppe Viale, Jose Bines, Martine J Piccart, null null
Adjuvant Pertuzumab and Trastuzumab in Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the APHINITY Trial: Third Interim Overall Survival Analysis With Efficacy Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Seock-Ah Im, Javier Cortes, David W Cescon, Mastura Md Yusof, Hiroji Iwata, Norikazu Masuda, Toshimi Takano, Chiun-Sheng Huang, Chi-Feng Chung, Koichiro Tsugawa, Yeon Hee Park, Koji Matsumoto, Kenichi Inoue, Ava Kwong, Sherene Loi, Wei Fu, Wilbur Pan, Vassiliki Karantza, Hope S Rugo, Peter Schmid
Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC. NPJ breast cancer 10 (1) (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Matteo Dugo, Chiun-Sheng Huang, Daniel Egle, Begoña Bermejo, Claudio Zamagni, Robert S Seitz, Tyler J Nielsen, Marc Thill, Antonio Antón-Torres, Stefania Russo, Eva Ciruelos Gil, Brock L Schweitzer, Douglas Teller Ross, Barbara Galbardi, Richard Greil, Vladimir Semiglazov, Gyorffy Balazs, Marco Colleoni, Catherine M Kelly, Gabriella Mariani, Lucia Del Mastro, Olivia Blasi, Maurizio Callari, Lajos Pusztai, Pinuccia Valagussa, Giuseppe Viale, Luca Gianni, Giampaolo Bianchini
The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Priya Rastogi, Joyce O'Shaughnessy, Miguel Martin, Frances M Boyle, Javier Cortes, Hope S Rugo, Matthew P Goetz, Erika Paige Hamilton, Chiun-Sheng Huang, Elzbieta Senkus, Alexey A Tryakin, Irfan Cicin, Laura Testa, Patrick Neven, Jens Huober, Zhi-Ming Shao, Ran Wei, Valérie André, Maria Munoz, Belen San Antonio, Ashwin Shahir, Nadia Harbeck, Stephen R D Johnston
Adjuvant Abemaciclib Plus Endocrine Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative, High-Risk Early Breast Cancer: Results From a Preplanned monarchE Overall Survival Interim Analysis, Including 5-Year Efficacy Outcomes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Michael Gnant, Khatijah Lim Abdullah, Frances M Boyle, Chiun-Sheng Huang, Katie Bickford, Sola Quasheba Neunie, Alexander Daniel Noble, Anne Nunn, Caroline Sproat, Nadia Harbeck, Carlos Henrique Barrios
Assessing Knowledge, Competence, and Performance Following Web-Based Education on Early Breast Cancer Management: Health Care Professional Questionnaire Study and Anonymized Patient Records Analysis. JMIR formative research 8 (2024)
Sung-Hsin Kuo, Ming-Feng Wei, Yi-Hsuan Lee, Jui-Chueh Lin, Wen-Chi Yang, Shi-Yi Yang, Chiun-Sheng Huang
MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer. Cellular oncology (Dordrecht) (2023)
Carsten Denkert, Chiara Lambertini, Peter Andreas Fasching, Katherine L Pogue-Geile, Max Senna Mano, Michael Untch, Norman Wolmark, Chiun-Sheng Huang, Sibylle Loibl, Eleftherios P P Mamounas, Charles E Geyer, Peter C Lucas, Thomas Boulet, Chunyan Song, Gail D Lewis Phillips, Malgorzata Nowicka, Sanne de Haas, Mark Basik
Biomarker Data From the Phase III KATHERINE Study of Adjuvant T-DM1 Versus Trastuzumab for Residual Invasive Disease After Neoadjuvant Therapy for HER2-Positive Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Po-Han Lin, Yun-Wen Tien, Wen-Fang Cheng, Ying Cheng Chiang, Chien-Huei Wu, Karen Yang, Chiun-Sheng Huang
Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome. Journal of gynecologic oncology (2023)
Po-Han Lin, Shin-Cheh Chen, Ling-Ming Tseng, King-Jen Chang, Ai-Chu Huang, Kuo-Chih Cheng, Karen Yang, Hui-Chen Wu, Tsu-Yi Chao, Yuan-Ching Chang, Peng-Chan Lin, Wen-Hung Kuo, Wen-Lin Kuo, Ching-Hung Lin, Huo-Mu Chen, Dah-Cherng Yeh, Liang-Chih Liu, Chun-Yu Liu, Ming-Yang Wang, Chiao Lo, Yen-Shen Lu, Chiun-Sheng Huang
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients. Breast cancer research and treatment 192 (3) (2022)
Sibylle Loibl, Chiun-Sheng Huang, Max S Mano, Eleftherios P Mamounas, Charles E Geyer, Michael Untch, Jean-Christophe Thery, Ingo Schwaner, Steven Limentani, Niklas Loman, Kristina Lübbe, Jenny C Chang, Thomas Hatschek, David Tesarowski, Chunyan Song, Sanne Lysbet de Haas, Thomas Boulet, Chiara Lambertini, Norman Wolmark
Adjuvant trastuzumab emtansine in HER2-positive breast cancer patients with HER2-negative residual invasive disease in KATHERINE. NPJ breast cancer 8 (1) (2022)
Ching-Hung Lin, Ruby Yun-Ju Huang, Tzu-Pin Lu, Kuan-Ting Kuo, Ko-Yun Lo, Ching-Hsuan Chen, I-Chun Chen, Yen-Shen Lu, Eric Y Chuang, Jean Paul Thiery, Chiun-Sheng Huang, Ann-Lii Cheng
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia. NPJ breast cancer 7 (1) (2021)
Ian E Krop, Seock-Ah Im, Carlos Henrique Barrios, Hervé R Bonnefoi, Julie R Gralow, Masakazu Toi, Paul A Ellis, Luca Gianni, Sandra M Swain, Young-Hyuck Im, Michelino De Laurentiis, Zbigniew Nowecki, Chiun-Sheng Huang, Louis Fehrenbacher, Yoshinori Ito, Jigna Shah, Thomas Boulet, Haiying Liu, Harrison Macharia, Peter Trask, Chunyan Song, Eric P Winer, Nadia Harbeck
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)